Mechanisms of target organ damage caused by hypertension: therapeutic potential

G Cohuet, H Struijker-Boudier - Pharmacology & therapeutics, 2006 - Elsevier
Hypertension is a major risk factor for cardiovascular mortality and morbidity through its
effects on target organs like the brain, heart, and kidney. Structural alterations in the …

Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses

Z Gaciong, M Siński, J Lewandowski - Current hypertension reports, 2013 - Springer
Stroke is the second most common cause of death worldwide and of adult disability, but in
the near future the global burden of cerebrovascular diseases will rise due to ageing and …

Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension …

E Salvi, Z Kutalik, N Glorioso, P Benaglio, F Frau… - …, 2012 - Am Heart Assoc
Essential hypertension is a multifactorial disorder and is the main risk factor for renal and
cardiovascular complications. The research on the genetics of hypertension has been …

The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction

G Mancia - Acta Diabetologica, 2005 - Springer
Diabetes and hypertension frequently coexist, and their combination provides additive
increases in the risk of life-threatening cardiovascular events. Recent guidelines agree on …

Prevention and treatment of the metabolic syndrome

SS Daskalopoulou, DP Mikhailidis, M Elisaf - Angiology, 2004 - journals.sagepub.com
The prevalence of the metabolic syndrome is increasing owing to lifestyle changes leading
to obesity. This syndrome is a complex association of several interrelated abnormalities that …

Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14–effects of different classes of antihypertensive drugs in older and younger …

C Thomopoulos, G Parati, A Zanchetti - Journal of hypertension, 2018 - journals.lww.com
Methods: Two databases we had previously identified [72 placebo-controlled BP-lowering
randomized clinical trials (RCTs) in 260 210 individuals and 50 RCTs head-to-head …

Management of traditional cardiovascular risk factors in CKD: what are the data?

LP Gregg, SS Hedayati - American Journal of Kidney Diseases, 2018 - Elsevier
Patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) are 10 times
more likely to die of cardiovascular (CV) diseases than the general population, and dialysis …

Calcium antagonists

E Grossman, FH Messerli - Progress in Cardiovascular Diseases, 2004 - Elsevier
Calcium antagonists were introduced for the treatment of hypertension in the 1980s. Their
use was subsequently expanded to additional disorders, such as angina pectoris …

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial

SE Kjeldsen, S Julius, G Mancia… - Journal of …, 2006 - journals.lww.com
Objective To test for the first time the hypothesis that treatment of hypertensive patients at
high cardiovascular risk with the angiotensin-receptor blocker (ARB) valsartan prevents new …

Pharmacotherapy for hypertension in adults aged 18 to 59 years

VM Musini, F Gueyffier, L Puil… - Cochrane Database …, 2017 - cochranelibrary.com
Background Hypertension is an important risk factor for adverse cardiovascular events
including stroke, myocardial infarction, heart failure and renal failure. The main goal of …